BRC reports its fiscal Q4 results today with investors watching to see whether the company can follow one of its largest single-day moves in recent memory.
The clearest precedent is last quarter's print. In May, Brady jumped more than 20% in a single session and sustained nearly 24% over the following five days — an unusually strong post-earnings reaction for an industrial company of its profile. That move has set expectations high. The stock is now up roughly 15% year-to-date, though it has retraced nearly 6% over the past month and shed another 3.3% in the past week, closing at $90.34. Options positioning is broadly neutral heading in: the put/call ratio is running at 0.94, barely above its 20-day average of 0.88, with a z-score near zero. Neither bulls nor bears are pressing hard in the derivatives market ahead of the release.
Short interest is essentially a non-story here. Bears hold just 1.5% of the free float — a low conviction position — and that share has been drifting lower for a month, down roughly 3% over both the past week and the past month. Borrow availability is extraordinarily loose, with nearly 8,300% of short interest available to lend. Cost to borrow remains negligible at around 0.5%, up modestly on the week but well within a normal range. There is no squeeze dynamic, no borrow stress, and no sign that short sellers have a high-conviction view on the downside.
The more interesting context is insider activity. On September 1 — three days before today's print — multiple executives received equity grants and simultaneously sold shares to cover tax obligations, a routine compensation-related pattern rather than a discretionary view signal. The CFO, COO, General Counsel, and President of Americas & Asia all filed transactions of the type F (tax withholding), with no open-market purchases or sales on record. None of these are conviction trades. FMR LLC remains the largest disclosed institutional holder at roughly 15% of shares, having grown its stake from 13.7%, while Neuberger Berman trimmed its position from 5.5% to 4.5% — a modest reduction that brought it below the 5% disclosure threshold.
On the analyst side, only one recent action carries weight: Sidoti & Co. upgraded Brady to Buy in June with a $103 target. The consensus mean price target is $110, implying roughly 22% upside from the current price — a reasonably constructive Street view, though the most recent bellwether-firm rating data in the snapshot dates to early 2024 and should be treated with caution. Brady's dividend score ranks in the 95th percentile, reflecting its long-running shareholder return commitment, and its ORTEX short score of 30.8 is low and stable, suggesting no escalation in bearish signals.
The print will test whether Brady's May surprise was a one-off or the start of a durable re-rating — and whether management's guidance supports the $110 consensus target that the Street is currently anchored to.
See the live data behind this article on ORTEX.
Open BRC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
